NASDAQ:ARWR   Arrowhead Pharmaceuticals, Inc.
0
What about a short position on a company from the much talked-of biotechnology sector, where bubbles continue to blow off.
Here, companies have closed below the USD 5.47 support level for the second consecutive session. For those who are guided by the technical analysis in their decisions – if the gauge breaks through the support level and this move is confirmed, it is advised to open short positions.
The latest financial results of the company do not give grounds for recommendation for including the stock in the investment portfolio.
In the upshot – a short position with the USD 3.70 target.
I am taking part in Market Forecaster competition. Vote for my forecast at
s30401946468.whotrad...com/blog/43240897127
link and help me win first prize. Thank you!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.